MiriamBenedicta(Louthan)VosMD

Pediatric Hepatology and Liver Transplantation

Physician

Dr. Vos is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1760 Haygood Dr
Emory University, Health Sciences Research Building
Atlanta, GA 30322
Phone+1 404-727-9930

University of Louisville School of MedicineFellowship, Pediatric Gastroenterology, 2002 - 2005
University of Louisville School of MedicineResidency, Pediatrics, 1999 - 2002
University of Louisville School of MedicineClass of 1999

Effects of Dietary Fructose Reduction in Children With Hepatic Steatosis Start of enrollment: 2009 Jun 01
Completed
Not Applicable
Human Heterologous Liver Cells for Infusion in Children With Urea Cycle Disorders Start of enrollment: 2010 Dec 01
Terminated
Phase 2
Dietary Treatment Study of Pediatric NAFLD Start of enrollment: 2015 Jul 01
Completed
Not Applicable
Anti-LPS Antibody Treatment for Pediatric NAFLD Start of enrollment: 2017 Feb 01
Completed
Phase 2
Gemcabene for the Treatment of Pediatric NAFLD Start of enrollment: 2018 Mar 29
Terminated
Phase 2
Prevention of NAFLD in Hispanic Children Start of enrollment: 2022 Apr 06
Recruiting
Not Applicable
Roles: Contact, Principal Investigator
Non-Invasive Diagnostic Tests for MASLD in Pediatric Population Start of enrollment: 2024 Jan 18
Recruiting
Not Applicable
Roles: Contact, Principal Investigator
Join now to see all

PubMed

Pediatric MASLD: current understanding and practical approach.
Anne-Sophie R Stroes, Miriam Vos, Marc A Benninga, Bart G P Koot
European Journal of Pediatrics. 2024-11-19
Environmental toxicants modulate disease severity in pediatric metabolic dysfunction-associated steatohepatitis.
Ajay K Jain, Stefanie A Busgang, Chris Gennings, Katherine P Yates, Jeffrey B Schwimmer
Journal of Pediatric Gastroenterology and Nutrition. 2024-11-01
1 citations
Renal impairment is prevalent in pediatric NAFLD/MASLD and associated with disease severity.
Marialena Mouzaki, Katherine P Yates, Ana Catalina Arce-Clachar, Cindy Behling, Niviann M Blondet
Journal of Pediatric Gastroenterology and Nutrition. 2024-08-01

Journal Articles

Copper-Fructose Interactions: A Novel Mechanism in the Pathogenesis of NAFLD
Miriam B Vos, Craig J McClain, MDPI
A Randomized, Controlled, Crossover Pilot Study of Losartan for Pediatric Nonalcoholic Fatty Liver Disease
Saul Karpen, Jennifer K Frediani, Miriam B Vos, BioMed Central

New Target RWE Research Validates Updated Liver Disease Terminology in ChildrenNovember 25th, 2024
This Is Your Body on SugarOctober 30th, 2024
Large Real-World Study Uncovers Higher Prevalence of Non-Alcoholic Fatty Liver Disease Markers, Liver Biopsy, and Cirrhosis in ChildrenMarch 29th, 2022
Join now to see all

Dietary Fructose And Redox Effects In Pediatric Nonalcoholic Fatty Liver DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2011